MALDI imaging identifies prognostic seven-protein signature of novel tissue markers in intestinal-type gastric cancer. - Test2 - elhamkhani - TriplyDB

MALDI imaging identifies prognostic seven-protein signature of novel tissue markers in intestinal-type gastric cancer.

MALDI imaging identifies prognostic seven-protein signature of novel tissue markers in intestinal-type gastric cancer.

http://www.wikidata.org/entity/Q34052933

about

Perspectives on new biomarkers in gastric cancer: diagnostic and prognostic applications Recent advances in mass spectrometry-based proteomics of gastric cancer Mass spectrometry imaging with high resolution in mass and space.Analysis of tissue specimens by matrix-assisted laser desorption/ionization imaging mass spectrometry in biological and clinical research.Top-down proteomics with mass spectrometry imaging: a pilot study towards discovery of biomarkers for neurodevelopmental disorders MALDI FTICR IMS of Intact Proteins: Using Mass Accuracy to Link Protein Images with Proteomics Data Quantitative proteomic analysis of gastric cancer tissue reveals novel proteins in platelet-derived growth factor b signaling pathway HFIP extraction followed by 2D CTAB/SDS-PAGE separation: a new methodology for protein identification from tissue sections after MALDI mass spectrometry profiling for personalized medicine research Matrix assisted laser desorption ionization mass spectrometry imaging identifies markers of ageing and osteoarthritic cartilage.Imaging mass spectrometry in papillary thyroid carcinoma for the identification and validation of biomarker proteins.Matrix-assisted laser desorption ionization-imaging mass spectrometry: a new methodology to study human osteoarthritic cartilage.Matrix-assisted laser desorption/ionization imaging protocol for in situ characterization of tryptic peptide identity and distribution in formalin-fixed tissue.Repeat MALDI MS imaging of a single tissue section using multiple matrices and tissue washes.Current frontiers in clinical research application of MALDI imaging mass spectrometry.Comprehensive identification of proteins from MALDI imaging.Treatment of nasopharyngeal carcinoma cells with the histone-deacetylase inhibitor abexinostat: cooperative effects with cis-platin and radiotherapy on patient-derived xenografts.Tumoral heterogeneity of hepatic cholangiocarcinomas revealed by MALDI imaging mass spectrometry.De novo discovery of phenotypic intratumour heterogeneity using imaging mass spectrometry.Proteomic and metabolic prediction of response to therapy in gastric cancer.High-resolution MALDI mass spectrometric imaging of lipids in the mammalian retina.MALDI Imaging mass spectrometry: current frontiers and perspectives in pathology research and practice.Filter-Dense Multicolor Microscopy Imaging phosphorylated peptide distribution in human lens by MALDI MS.Recent progress in protein profiling of clinical tissues for next-generation molecular diagnostics.MALDI mass spectrometry imaging analysis of pituitary adenomas for near-real-time tumor delineation CRIP1 expression is correlated with a favorable outcome and less metastases in osteosarcoma patients.Langartech: A Custom-Made MALDI Matrix Sprayer for MALDI Imaging Mass Spectrometry.Progress in the development of protein biomarkers of oesophageal and gastric cancers.The use of matrix coating assisted by an electric field (MCAEF) to enhance mass spectrometric imaging of human prostate cancer biomarkers.MALDI imaging mass spectrometry as a novel tool for detecting histone modifications in clinical tissue samples.What gastric cancer proteomic studies show about gastric carcinogenesis?MALDI mass spectrometry imaging: A cutting-edge tool for fundamental and clinical histopathology.MALDI Mass Spectrometry Imaging Reveals Decreased CK5 Levels in Vulvar Squamous Cell Carcinomas Compared to the Precursor Lesion Differentiated Vulvar Intraepithelial Neoplasia.High-mass-resolution MALDI mass spectrometry imaging of metabolites from formalin-fixed paraffin-embedded tissue.MALDI Mass Spectrometry Imaging of N-Linked Glycans in Cancer Tissues.A technique for relative quantitation of cancer biomarkers in formalin-fixed, paraffin-embedded (FFPE) tissue using stable-isotope-label based mass spectrometry imaging (SILMSI).The impact of cysteine-rich intestinal protein 1 (CRIP1) in human breast cancer A new look at drugs targeting malignant melanoma--an application for mass spectrometry imaging.Molecular histology of arteries: mass spectrometry imaging as a novel ex vivo tool to investigate atherosclerosis.Mass spectrometry imaging for clinical research - latest developments, applications, and current limitations.

P2860

Q27012898-BC2EC2E8-53A0-4801-9327-509D96D24061 Q28075514-241B7EA3-B569-472D-9B59-D97F18DB7E37 Q28383071-360B5775-C587-4A16-81E1-140F82EB3D04 Q28396816-8B15AB99-9A2C-45C2-B616-3A5DDED9C709 Q28542079-93C7859A-2285-46EA-887C-9D3CDED35E00 Q30938681-E6A0C507-98FF-4CD7-8C84-1579F0B9F4E1 Q33591805-7E5A2757-893C-4BB1-8C03-6E31E4D3BDA1 Q33722914-2BC523FA-85BE-493E-BC80-0F9B94083050 Q33892773-1389CF03-C535-433B-A871-9B65E9232CD7 Q33913712-85FA6A00-0743-48C2-A3F0-9575A4DFB99A Q34529048-B8371CDF-37A9-40CB-A091-682549EEEA3A Q34589419-CAAA8F4B-6381-4B00-82B3-54029E610889 Q34628921-AF8DCDF7-2E9B-4A78-A5A3-2757421F269B Q34777079-51168940-6A57-4536-B4FA-F6D1930A3479 Q34778073-2A5AAE6F-CCB3-43FD-9BA0-F168FFD6B582 Q35117590-B4913439-B633-4B5C-9CC7-B5496C08DDE4 Q35134122-BFFFCDEE-6E09-43FB-932E-E2C69F2FBD37 Q35243470-7245E31E-2854-4DAE-8661-6A64ADD42BF2 Q35336183-F5397054-DD72-431F-83AE-146D73863C57 Q35532825-60BDA32A-1446-4BCA-B81E-F9042DC2F085 Q35549222-02F434A4-1035-41BE-9FEF-A5C555D36AAC Q35571593-36CC288A-31BC-4598-B04D-70088FD2096D Q35622625-2E7D344F-50D2-49F7-8AA3-2A25B0415223 Q35714211-AC2C0F0C-99DB-44BC-A539-DC8F5AB466C4 Q35718041-61240382-3853-4AA0-BC40-71FD0B5C6D0C Q35764430-F00DD082-437C-4E75-BA77-ACA3D659FA64 Q35782287-E9D096EB-4335-4D42-A77D-F279C053E79E Q35845797-458377AD-2A1D-4F8B-9A23-C0CF0B130877 Q35891644-F8619ED7-7FDB-4E36-9BA1-750F197A7B59 Q35903773-2369C127-E6BA-49A8-86C8-883395652D49 Q36002404-E88C9F1D-3239-40BF-8312-E592DBDD794E Q36020378-2470B71F-0CCB-430F-867B-060912895184 Q36072649-8719F952-D4A0-4D8C-A939-D328E2E1D273 Q36077253-D26E7222-89CA-49FC-AABC-08D879B2AA34 Q36256730-1A7BE993-B177-4038-85C3-FCF42D167B89 Q36321687-D486A7A9-2E8C-4D6A-BB40-A45A2D9440E6 Q36884986-8722B812-19FD-4E03-A74B-F537252B5C33 Q38232032-0A035500-9484-45C2-824F-14E36572823A Q38630695-83D409AE-B26D-4327-B604-880A1ED5664D Q38712870-03C1F59B-7539-43D2-ADE8-185452341A76

P2860

MALDI imaging identifies prognostic seven-protein signature of novel tissue markers in intestinal-type gastric cancer.

http://www.wikidata.org/entity/Q34052933

description

2011 nî lūn-bûn

@nan

2011 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

MALDI imaging identifies progn ...... ntestinal-type gastric cancer.

@ast

MALDI imaging identifies progn ...... ntestinal-type gastric cancer.

@en

MALDI imaging identifies progn ...... ntestinal-type gastric cancer.

@nl

type

label

MALDI imaging identifies progn ...... ntestinal-type gastric cancer.

@ast

MALDI imaging identifies progn ...... ntestinal-type gastric cancer.

@en

MALDI imaging identifies progn ...... ntestinal-type gastric cancer.

@nl

prefLabel

MALDI imaging identifies progn ...... ntestinal-type gastric cancer.

@ast

MALDI imaging identifies progn ...... ntestinal-type gastric cancer.

@en

MALDI imaging identifies progn ...... ntestinal-type gastric cancer.

@nl

P1433

Q34052933-6BA4086B-197A-4290-8060-EFB80A45F06A

P1476

Q34052933-1F92F14B-3ECD-4B62-B604-9A1F093F5E0E

P2093

Q34052933-0242A476-ADF7-4C7D-B502-3BD21688F7CD

Q34052933-0C18AFAE-1E71-463B-9D53-00F94CD51161

Q34052933-146AA45C-4234-48E6-879E-B8CA094C7324

Q34052933-1E9235AB-2AD3-45BB-9B24-8033C58EB891

Q34052933-2B628705-445E-4876-8B98-7036EA00E0EC

Q34052933-43D83FFA-792C-4F13-8B17-A5F050AE93A5

Q34052933-712E5463-40C1-42B7-A27E-0CFD3F178D6B

Q34052933-75754025-E01D-4151-9741-1B3B624C299A

Q34052933-8483E83F-0037-4691-9D59-D3EFD0A82515

Q34052933-8E8B6794-D2E2-400D-962F-608419E67A7F

P2860

Q34052933-0F41DA42-6641-47DB-A00F-FC1800164532

Q34052933-14587C36-9D58-438F-B490-1D4D3F078A9D

Q34052933-17756C0E-B770-4B2F-A87D-5D2BCB8B5431

Q34052933-1820DD30-0AF2-49B2-9E36-2FC1D97EA320

Q34052933-1AA6D07C-1B06-4985-B7C4-79A46F30E38C

Q34052933-1C6EE7AB-EB16-4EC2-8DB6-D6D787604479

Q34052933-1D251681-D00F-4BF0-9AA4-B834D090A950

Q34052933-20716A6D-8CA8-4C85-9D3F-6A3D2FAF5FF5

Q34052933-2CA559E1-58C2-4736-B689-805551320A1C

Q34052933-2D804874-BEE4-4D56-B375-2B546E906260

P304

Q34052933-C9D3F6ED-1259-430F-B08B-298A6108F137

P31

Q34052933-2C39A5E0-A444-4EEF-B64E-9B450D9726C0

P356

Q34052933-84A66F9A-0464-4624-A9B3-7B2D9F062F9C

P407

Q34052933-272A3C20-619C-455A-A723-1DAF9375DEAD

P433

Q34052933-3E7AE2B5-04EB-48A9-B25C-84AADC22784D

P478

Q34052933-ADD53993-ECE0-4DBD-B21E-07524FD18644

P577

Q34052933-582E7E9D-791B-4841-B267-6337F08CB8DE

P5875

Q34052933-2F1E5593-ADE7-44E6-BEB9-58F17CAAA65C

P698

Q34052933-75CDD8C9-195B-4479-8B8C-CEBB4EB40DF9

P921

Q34052933-2A78DA8E-176B-48E1-A72A-F64BECFCCA3F

P932

Q34052933-24DEEC4B-6BA2-40F7-9FBA-82ADAB7B589B

P356

J.AJPATH.2011.08.032

P1433

The American Journal of Pathology

P1476

MALDI imaging identifies progn ...... ntestinal-type gastric cancer.

@en

P2093

Alexander Novotny

http://www.w3.org/2001/XMLSchema#string

Annette Feuchtinger

http://www.w3.org/2001/XMLSchema#string

Axel Walch

http://www.w3.org/2001/XMLSchema#string

Benjamin Balluff

http://www.w3.org/2001/XMLSchema#string

Cedrik Schöne

http://www.w3.org/2001/XMLSchema#string

Christoph Schuhmacher

http://www.w3.org/2001/XMLSchema#string

Giuseppina Maccarrone

http://www.w3.org/2001/XMLSchema#string

Hakan Sarioglu

http://www.w3.org/2001/XMLSchema#string

Heinz Höfler

http://www.w3.org/2001/XMLSchema#string

Herbert Braselmann

http://www.w3.org/2001/XMLSchema#string

P2860

Upregulated expression of human neutrophil peptides 1, 2 and 3 (HNP 1-3) in colon cancer serum and tumours: a biomarker study

Hypomethylation of WNT5A, CRIP1 and S100P in prostate cancer

S100A6 binds to annexin 2 in pancreatic cancer cells and promotes pancreatic cancer cell motility

Human cysteine-rich intestinal protein: cDNA cloning and expression of recombinant protein and identification in human peripheral blood mononuclear cells

Identification and rational redesign of peptide ligands to CRIP1, a novel biomarker for cancers

Nuclear LIM interactor, a rhombotin and LIM homeodomain interacting protein, is expressed early in neuronal development

Significance analysis of microarrays applied to the ionizing radiation response

Cancer statistics, 2008

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

Human defensins as cancer biomarkers and antitumour molecules

P304

2720-2729

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.AJPATH.2011.08.032

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

179

http://www.w3.org/2001/XMLSchema#string

P577

2011-10-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51735207

http://www.w3.org/2001/XMLSchema#string

P698

22015459

http://www.w3.org/2001/XMLSchema#string

P921

matrix-assisted laser desorption/ionization

P932

3260837

http://www.w3.org/2001/XMLSchema#string